Report #2873420

Received Nov 18, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 63 yrs
State: IA
Recovered: Unknown
Vaccinated: Nov 13, 2025
Onset: Nov 13, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
FLU3	INFLUENZA (SEASONAL) (FLUARIX)	GLAXOSMITHKLINE BIOLOGICALS	2	JE74J	—

Symptoms (1)

Extra dose administered

Symptom narrative

a patient received 2 doses of Fluarix; This non-serious case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 63-year-old female patient who received Flu Seasonal TIV Dresden (Fluarix 2025-2026 season) (batch number JE74J, expiry date 30-JUN-2026) for prophylaxis. Concomitant products included INFLUENZA VACCINE INACT SPLIT 3V (FLUARIX). On 13-NOV-2025, the patient received the 2nd dose of Fluarix 2025-2026 season .5 ml. On 13-NOV-2025, an unknown time after receiving Fluarix 2025-2026 season, the patient experienced extra dose administered (Verbatim: a patient received 2 doses of Fluarix). The outcome of the extra dose administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 13-NOV-2025 CNA reported that a patient received 2 doses of Fluarix, one dose received on 24-SEP-2025 and one today on the day of reporting. The batch number was not provided upon follow- up with the reporter.

Other medications

FLUARIX